These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3195349

  • 1. [Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice].
    He H, Wang MY, Zhang TM.
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):369-73. PubMed ID: 3195349
    [No Abstract] [Full Text] [Related]

  • 2. [Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
    Graczyk J, Pakulska W, Groszkowski S, Najman L.
    Acta Pol Pharm; 1980 Jul; 37(2):249-54. PubMed ID: 7468274
    [No Abstract] [Full Text] [Related]

  • 3. Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.
    Wilkoff LJ, Lloyd HH, Dulmadge EA, Dixon GJ.
    J Natl Cancer Inst; 1970 Jan; 44(1):201-9. PubMed ID: 11515031
    [No Abstract] [Full Text] [Related]

  • 4. Dioxopiperazine derivative potentiates antitumor effect of methylglyoxal bis(cyclopentylamidinohydrazone) on human and mouse leukemia cells.
    Hibasami H, Tsukada T, Shirakawa S, Narita T, Inagaki M, Nakashima K.
    Anticancer Res; 1994 Jan; 14(2A):561-4. PubMed ID: 8017861
    [Abstract] [Full Text] [Related]

  • 5. [Effect of selected piperazine derivatives on the metabolic clearance rate of idoxuridine-I-125 in mice with transplanted leukemia L1210].
    Graczyk J, Kowalczyk K, Pakulska W, Szadowska A.
    Acta Pol Pharm; 1981 Jan; 38(6):717-21. PubMed ID: 7348532
    [No Abstract] [Full Text] [Related]

  • 6. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Woodman RJ, Sirica AE, Gang M, Kline I, Venditti JM.
    Chemotherapy; 1973 Jan; 18(3):169-83. PubMed ID: 4119363
    [No Abstract] [Full Text] [Related]

  • 7. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
    Ochocki J, Glinka R, Cieśliński M, Góra-Tybor J, Potemski P.
    Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The acute toxicity and in vivo antitumour activity against L1210 leukemia of triphenyltin 3,5-diisopropylsalicylate, bis (di-n-butyl-(s)-2-pyrrolidone-5-carboxylato)tin oxide and di-n-butyltin bis(3-amino-4-methylbenzoate).
    Gielen M, de Vos D, Meriem A, Boualam M, el Khloufi A, Willem R.
    In Vivo; 1993 Jul; 7(2):171-4. PubMed ID: 8364169
    [Abstract] [Full Text] [Related]

  • 10. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Salsbury AJ, Burrage K, Hellmann K.
    Cancer Res; 1974 Apr; 34(4):843-9. PubMed ID: 4814997
    [No Abstract] [Full Text] [Related]

  • 11. Effects of methylglyoxal-bis(guanylhydrazone) on polyamine metabolism in spleens of mice with disseminated L1210 lymphoid leukemia.
    Heby O, Russell DH.
    Cancer Res; 1974 Apr; 34(4):886-92. PubMed ID: 4815000
    [No Abstract] [Full Text] [Related]

  • 12. [Development of leukemia L-1210 after treatment with the methionine synthetase inhibitor quinoline dibromide].
    Kudriavtsev IA, Paramonova TD, Golenko OD, Miasishcheva NV.
    Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):27-31. PubMed ID: 7122454
    [No Abstract] [Full Text] [Related]

  • 13. Experimental studies on the antitumor effect of ethidium bromide and related substances.
    Nishiwaki H, Miura M, Imai K, Ono R, Kawashima K.
    Cancer Res; 1974 Oct; 34(10):2699-703. PubMed ID: 4413384
    [No Abstract] [Full Text] [Related]

  • 14. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
    WU FY, Le Pecq JB.
    Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
    [No Abstract] [Full Text] [Related]

  • 15. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP, Trader MW, Frei E, Peters WP, Wolpert MK, Laster WR.
    Cancer Res; 1987 May 01; 47(9):2323-7. PubMed ID: 3567926
    [Abstract] [Full Text] [Related]

  • 16. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
    Mihich E, Mulhern AI.
    Cancer Res; 1968 Feb 01; 28(2):354-62. PubMed ID: 5641525
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ, Wilson GL, Mossman BT, Angelino N, Kanter PM, Korytnyk W.
    Cancer Res; 1985 Feb 01; 45(2):695-702. PubMed ID: 3881170
    [Abstract] [Full Text] [Related]

  • 19. Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.
    Mihich E.
    Cancer Res; 1969 Apr 01; 29(4):848-54. PubMed ID: 4887203
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.